Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part I
Jacqueline C. Barrientos, MD, MS, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
CAR T-cell Therapy in 2022: What You Need to Know
Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA
Highpoints from Attending the 2021 American Society of Hematology Conference
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Updates on COVID-19 in Patients with Blood Cancer
John P. Leonard, MD, Weill Cornell Medicine, New York Presbyterian, New York, NY
A Conversation on Adult Survivorship
Maria Alma Rodriguez, MD, MACP, CMQ, The University of Texas MD Anderson Cancer Center, Houston, TX
The Advanced Practice Provider’s Role in Treating Newly Diagnosed Patients with Myeloma
Daniel Verina, DNP, ACNP-BC, Mount Sinai Medical Center, New York, NY
The Physician’s Role in Treating Newly Diagnosed Patients with Myeloma
Joshua Richter, MD, Icahn School of Medicine at Mount Sinai, New York, NY
Clinical Trials: A Healthcare Professional’s Perspective
Lorenzo Falchi, MD and Leah Szumita, MS, RN, CCRN, ACNS-BC
Wearing Two Hats: Supporting the Childhood Cancer Patient as Nurse & Parent
David Tate, BSN, RN, PHN, Rio Bravo-Greeley School, Bakersfield, CA
Addressing Healthcare Disparities in Cancer Care
Justine M. Kahn, MD, MS, Columbia University Irving Medical Center, New York, NY
T-cell Lymphoma: A Discussion on Treatment and Patient Support
Steven Horwitz, MD, Memorial Sloan Kettering Cancer Center, New York, NY
A Discussion on MRD: Practical Information for Providers
Jeffrey L. Wolf, MD, University of California San Francisco, San Francisco, CA
A Deeper Dive into Cancer Genomics
Justin M. Watts, MD, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
The Pharmacist’s Role on the Blood Cancer Treatment Team
Peter Campbell, PharmD, BCOP, Columbia University Irving Medical Center, New York, NY
A Conversation on Multiple Myeloma with Edward Stadtmauer, MD
Edward A. Stadtmauer, MD, The University of Pennsylvania, Philadelphia, PA
The COVID-19 Vaccine and Your Patient with Cancer
Michael Angarone, DO, FIDSA, Feinberg School of Medicine, Chicago, IL
Managing Treatment for Patients with Relapsed/Refractory Lymphoma
Sonali M. Smith, MD, FASCO, The University of Chicago, Chicago, IL
What’s New in Treatment for Acute Myeloid Leukemia (AML)
Olatoyosi Odenike, MD and Wendy Stock, MD
Progress in the Treatment of Follicular Lymphoma
Jeff Sharman, MD, Willamette Valley Cancer Institute, Eugene, OR
Current Applications of Cancer Genomics: Focus on CLL
Jennifer Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA
Supporting LGBTQI Cancer Patients
Matthew B. Schabath, PhD, Moffitt Cancer Center, Tampa, FL
A Deeper Dive into MRD: A Conversation with Gail Roboz, MD
Gail J. Roboz, MD, Weill Cornell Medical College, New York, NY
Communicating with Caregivers: Strategies for HCPs
Allison J. Applebaum, Ph.D., Memorial Sloan Kettering Cancer Center, New York, NY
Communicating with the Young Adult with Blood Cancer
Carma Bylund, PhD, FACH, and Carla Fisher, PhD
Facilitating the Learning Experience of Children and AYAs During and After Cancer Treatment
Nicole Gutman, MS, and Mary Kay Irwin, EdD
Myelodysplastic Syndromes (MDS): Caring for Low and High-Risk Patients
James M. Foran, MD, FRCPC, Mayo Clinic Cancer Center, Jacksonville, FL
Treating Children with Cancer during the COVID-19 Pandemic
Jennifer Levine, MD, and Maria Luisa Sulis, MD, MS
CML: Treatment Considerations and Survivorship Challenges
Alison Loren, MD, MSCE, Raymond and Ruth Perelman School of Medicine, Philadelphia, PA
Understanding the Complexities of Myeloproliferative Neoplasms
Raajit K. Rampal, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY
COVID-19: What Healthcare Professionals Need to Know
Tobias M. Hohl, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY